BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jan 04, 2010
 |  BioCentury  |  Strategy

Going for attention: Teva's deal making

Going for attention: Teva's deal making

While Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) is best known for its generics business, at least 17 of the pharma's 26 in-licensing or...

Read the full 117 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >